Pnc Financial Services Group, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,666 shares of ARWR stock, worth $41,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,666

Previous 3,485 23.5%

Holding current value

$41,856

Previous $65,000 49.23%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$12.74 - $21.53 $10,434 - $17,633	-819 Reduced 23.5%	2,666 $33,000
Q4 2024 Feb 07, 2025	SELL	$17.7 - $26.34 $22,620 - $33,662	-1,278 Reduced 26.83%	3,485 $65,000
Q3 2024 Nov 08, 2024	BUY	$19.36 - $29.54 $16,475 - $25,138	851 Added 21.75%	4,763 $92,000
Q2 2024 Aug 09, 2024	BUY	$21.87 - $28.24 $25,740 - $33,238	1,177 Added 43.03%	3,912 $101,000
Q1 2024 May 10, 2024	BUY	$27.21 - $39.48 $15,945 - $23,135	586 Added 27.27%	2,735 $78,000
Q4 2023 Feb 09, 2024	SELL	$21.2 - $31.03 $3,116 - $4,561	-147 Reduced 6.4%	2,149 $65,000
Q3 2023 Nov 13, 2023	SELL	$26.2 - $36.08 $538,043 - $740,938	-20,536 Reduced 89.94%	2,296 $61,000
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $29,663 - $48,787	1,179 Added 5.44%	22,832 $814,000
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $27,492 - $44,710	-1,161 Reduced 5.09%	21,653 $549,000
Q4 2022 Feb 10, 2023	SELL	$28.0 - $40.56 $16,380 - $23,727	-585 Reduced 2.5%	22,814 $925,000
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $33,926 - $55,314	1,145 Added 5.15%	23,399 $773,000
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $11,949 - $21,762	-430 Reduced 1.9%	22,254 $783,000
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $1,703 - $3,008	-43 Reduced 0.19%	22,684 $1.04 Million
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $25,094 - $35,644	432 Added 1.94%	22,727 $1.51 Million
Q3 2021 Nov 05, 2021	SELL	$58.38 - $84.96 $20,666 - $30,075	-354 Reduced 1.56%	22,295 $1.39 Million
Q2 2021 Aug 06, 2021	BUY	$62.15 - $90.32 $2,175 - $3,161	35 Added 0.15%	22,649 $1.88 Million
Q1 2021 May 07, 2021	BUY	$61.35 - $90.47 $9,570 - $14,113	156 Added 0.69%	22,614 $1.5 Million
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $42,198 - $82,211	963 Added 4.48%	22,458 $1.72 Million
Q3 2020 Nov 06, 2020	BUY	$33.21 - $51.27 $647,096 - $998,995	19,485 Added 969.4%	21,495 $925,000
Q2 2020 Aug 07, 2020	SELL	$26.12 - $43.27 $3,134 - $5,192	-120 Reduced 5.63%	2,010 $86,000
Q1 2020 May 08, 2020	SELL	$20.56 - $63.12 $5,592 - $17,168	-272 Reduced 11.32%	2,130 $61,000
Q4 2019 Feb 07, 2020	SELL	$28.14 - $73.01 $27,211 - $70,600	-967 Reduced 28.7%	2,402 $152,000
Q3 2019 Nov 08, 2019	BUY	$26.26 - $34.86 $14,915 - $19,800	568 Added 20.28%	3,369 $94,000
Q2 2019 Aug 09, 2019	BUY	$17.43 - $28.82 $48,821 - $80,724	2,801 New	2,801 $0
Q4 2018 Feb 08, 2019	SELL	$10.74 - $19.7 $4,296 - $7,880	-400 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$14.0 - $20.3 $5,600 - $8,120	400 New	400 $0

Others Institutions Holding ARWR

# of Institutions

300

Shares Held

98M

Call Options Held

306K

Put Options Held

432K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.66B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History